Skip to main content
. 2005 Feb;79(3):1686–1700. doi: 10.1128/JVI.79.3.1686-1700.2005

TABLE 3.

Infection of GHOST cellsa

Virus RTCN value
Parental CCR1 CCR2b CCR3 CCR5 CXCR4 GPR15 CXCR6
Aviremic individuals
    RH2-3 2C5 438 273 29
    RH2-3 3A6c 1,142 950 165
    RH2-3 3B3 1,285 1,154 310
    RH2-3 3C3 745 1,767 267
    RH2-3 4C5 704 725 161
    RH2-3 5B1 984 267 59
    RH2-3 6C6 507 284 153
    RH2-3 8A5 1,136 2,124 86
    RH2-3 8A3c 1,201 541 98
    RH2-3 3A3b 10 10 7 6 1,451 8 2,629 301
    RH2-13 1D4 1,043 1,378 108
    RH2-13 1D6 886 1,394 123
    RH2-13 3B4 972 1,144 39
    RH2-13 5C1 1,209 1,774 117
    RH2-13 5C3 825 446 67
    RH2-13 6A3 895 382 41
    RH2-13 6B5b 1,677 698 20
    RH2-13 7C3 1,287 150 18
    RH2-13 6A2b 11 14 9 7 1,847 6 3,812 188
    RH2-13 6B1c 6 8 8 7 1,052 6 2,004 533
    RH2-14 1A6 375 124 32
    RH2-14 1B1 331 179 38
    RH2-14 1C2 537 194 38
    RH2-14 1C3 407 239 40
    RH2-14 1D1 431 55 13
    RH2-14 2A2 623 184 54
    RH2-14 2A4 414 275 66
    RH2-14 2A5 593 155 53
    RH2-14 2D5 292 142 12
    RH2-22 1B4 491 97 32
    RH2-22 1B5b 778 84 18
    RH2-22 1C3 656 90 39
    RH2-22 2B2 514 46 22
    RH2-22 2C4 740 233 65
    RH2-22 3A1b 908 41 13
    RH2-22 2A4c 5 6 724 159 163
    RH2-22 1B1c 46 99 37 47 1,611 43 1,342 383
    RH2-22 1B2c 17 27 16 18 1,191 13 688 142
    RH2-22 2C2c 24 36 22 21 957 17 313 132
    RH2-8 3D5c 10 8 8 6 658 6 28 17
    RH2-4 4D1b 1,277 389 61
    RH2-4 3B1b 6 5 5 1,147 168 533
    RH2-4 4B2b 12 23 8 15 1,298 11 792 298
Viremic individuals
    Asymptomatic
        RH2-15 B9b 953 170 35
        RH2-15 E5 367 7
        RH2-15 H11 964 73 19
        RH2-15 A9b
        RH2-15 E10b 37 102 101 85
    Progressors
        RH2-1 A8b 132 27
        RH2-1 A9b 270 13
        RH2-1 C7b 129
        RH2-1 D8b 268 14
        RH2-1 D9b 239 8
        RH2-1 G7b 552 34
        RH2-5 1F10 982 946 221
        RH2-5 2C8 1,409 1,866 263
        RH2-5 2D11b 368 249 27
        RH2-5 2E6b 996 1,142 45
        RH2-5 2A12b 10 317 324 87
        RH2-5 2F10b 11 6 5 9 2,579 3,440 810
        RH2-7 D6 1,194 673 431
        RH2-7 E1 652 261 112
        RH2-7 E4b 423 211 55
        RH2-7 F3 938 685 35
        RH2-7 F4b 580 283 126
        RH2-7 B3c 11 17 9 23 641 11 1,192 145
        RH2-21 2B2c 62 283 152 23 48 511 34 9
        RH2-21 2F9c 81 218 159 16 33 446 28 7
        RH2-24 1E2 2,394 515 52
        RH2-24 2D7 2,098 1,288 265
        RH2-24 2E10 1,238 243 21
        RH2-24 2E9c 942 718 94
        RH2-24 2F11 1,158 122 17
        RH2-24 2G9 1,374 543 79
        RH2-24 2D8c 183 1,022 796 49 163 1,504 170 28
        RH2-24 2E8c 65 173 127 14 32 543 35 6
        RH2-24 2G7c 158 624 788 37 152 1,746 144 21
        RH2-24 2H11c 17 36 22 6 96
        RH2-26 1C1 1,652
        RH2-26 1D3 1,083
        RH2-26 2A1 1,710
        RH2-26 2A10 1,083
        RH2-26 2A12 634
        RH2-26 2B4 2,430
        RH2-26 2D3 2,919
        RH2-26 2E2 2,919
        RH2-26 2D9c 198 1,071 918 40 124 1,767 131 18
        RH2-26 2E9c 152 620 680 33 103 1,274 88 33
    Controls (CoR)d
        ACH208 (X4) 94 708 473 23 85 1,140 266 43
        ACH39 (X4R3) 80 429 299 204 53 624 100 33
        SIVrcm (R2X6) NT 710 NT NT NT 628
a

Shown are RTCN values, values <5 are considered negative (−).

b

Two times the standard amount of virus was used (see Materials and Methods).

c

Tested in two individual experiments, of which the average is shown.

d

HIV-1 and SIV variants with known coreceptor usage (indicated by parentheses) were included as controls. HIV-1 was tested multiple times; shown are the averages of nine (ACH208) and four (ACH39) experiments. NT, not tested.